[go: up one dir, main page]

ZA979151B - Pyrazolinones for treating impaired potency. - Google Patents

Pyrazolinones for treating impaired potency.

Info

Publication number
ZA979151B
ZA979151B ZA9709151A ZA979151A ZA979151B ZA 979151 B ZA979151 B ZA 979151B ZA 9709151 A ZA9709151 A ZA 9709151A ZA 979151 A ZA979151 A ZA 979151A ZA 979151 B ZA979151 B ZA 979151B
Authority
ZA
South Africa
Prior art keywords
pyrazolinones
treating impaired
potency
impaired potency
treating
Prior art date
Application number
ZA9709151A
Inventor
Michael Arlt
Rochus Jonas
Pierre Schelling
Maria Christadler
Franz-Werner Kluxen
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of ZA979151B publication Critical patent/ZA979151B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4152—1,2-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA9709151A 1996-10-14 1997-10-13 Pyrazolinones for treating impaired potency. ZA979151B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19642284A DE19642284A1 (en) 1996-10-14 1996-10-14 Pyrazolinones for the treatment of erectile dysfunction

Publications (1)

Publication Number Publication Date
ZA979151B true ZA979151B (en) 1998-05-11

Family

ID=7808669

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9709151A ZA979151B (en) 1996-10-14 1997-10-13 Pyrazolinones for treating impaired potency.

Country Status (14)

Country Link
EP (1) EP0930881A1 (en)
JP (1) JP2001501958A (en)
KR (1) KR20000049086A (en)
CN (1) CN1233178A (en)
AR (1) AR008494A1 (en)
AU (1) AU4945297A (en)
BR (1) BR9712307A (en)
CA (1) CA2268823A1 (en)
DE (1) DE19642284A1 (en)
HU (1) HUP0000233A3 (en)
NO (1) NO991734D0 (en)
PL (1) PL332821A1 (en)
WO (1) WO1998016224A1 (en)
ZA (1) ZA979151B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6410584B1 (en) 1998-01-14 2002-06-25 Cell Pathways, Inc. Method for inhibiting neoplastic cells with indole derivatives
US6200771B1 (en) 1998-10-15 2001-03-13 Cell Pathways, Inc. Method of using a novel phosphodiesterase in pharmaceutical screeing to identify compounds for treatment of neoplasia
US6133271A (en) * 1998-11-19 2000-10-17 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure thienopyrimidine derivatives
US6187779B1 (en) 1998-11-20 2001-02-13 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure to 2,8-disubstituted quinazoline derivatives
US6369092B1 (en) 1998-11-23 2002-04-09 Cell Pathways, Inc. Method for treating neoplasia by exposure to substituted benzimidazole derivatives
US6486155B1 (en) 1998-11-24 2002-11-26 Cell Pathways Inc Method of inhibiting neoplastic cells with isoquinoline derivatives
US6034099A (en) * 1998-11-24 2000-03-07 Cell Pathways, Inc. Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones
US6077842A (en) * 1998-11-24 2000-06-20 Cell Pathways, Inc. Method of inhibiting neoplastic cells with pyrazolopyridylpyridazinone derivatives
US6875575B1 (en) 1998-11-25 2005-04-05 Osi Pharmaceuticals, Inc. Diagnostic methods for neoplasia
US6020379A (en) * 1999-02-19 2000-02-01 Cell Pathways, Inc. Position 7 substituted indenyl-3-acetic acid derivatives and amides thereof for the treatment of neoplasia

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9311920D0 (en) * 1993-06-09 1993-07-28 Pfizer Ltd Therapeutic agents
DE19518082A1 (en) * 1995-05-17 1996-11-21 Merck Patent Gmbh 4 (-Arylaminomethylene) -2,4-dihydropyrazol-3-one

Also Published As

Publication number Publication date
DE19642284A1 (en) 1998-04-16
JP2001501958A (en) 2001-02-13
KR20000049086A (en) 2000-07-25
CN1233178A (en) 1999-10-27
NO991734L (en) 1999-04-13
HUP0000233A3 (en) 2001-06-28
EP0930881A1 (en) 1999-07-28
CA2268823A1 (en) 1998-04-23
AU4945297A (en) 1998-05-11
NO991734D0 (en) 1999-04-13
HUP0000233A2 (en) 2001-04-28
WO1998016224A1 (en) 1998-04-23
PL332821A1 (en) 1999-10-11
BR9712307A (en) 1999-08-31
AR008494A1 (en) 2000-01-19

Similar Documents

Publication Publication Date Title
ZA9710429B (en) Broad-spectrumδ-endotoxins.
ZA967315B (en) Biphenylamides.
ZA979199B (en) Aminothiophenecarboxamides.
ZA976168B (en) 3-Ureido-pyridofurans and -pyridothiophenes.
MX213417B (en) Phenylpyridazinones.
ZA97521B (en) 19-Nor-pregnene derivatives.
ZA977206B (en) Arylalkanoylpyridazines.
ZA964468B (en) Triazolylmethyl-cyclopentanols.
ZA978304B (en) 3-alkyl-3-phenyl-piperidines.
ZA961955B (en) Indazolecarboxamides.
HK1018457A1 (en) Alkylaminobenzothiazole and-benzoxazole derivatives.
ZA976056B (en) Block former.
ZA9711567B (en) Compounds.
DE69610844D1 (en) Hydroformylierungsverfahren.
ZA973209B (en) Therapeutic compounds.
ZA979151B (en) Pyrazolinones for treating impaired potency.
ZA975861B (en) Bromotiacumicin compounds.
ZA979725B (en) Benzoaxozole derivative.
ZA97572B (en) 1-pyrazol-3-ylethyl-4-indol-3-ylpiperidines.
ZA966399B (en) Endothelin-receptor-antagonists.
ZA977791B (en) GLP-1 derivatives.
ZA9710349B (en) Process for making benzisothiazolin-3-ones.
ZA976022B (en) Cycloalkano-pyridines.
ZA971466B (en) Endothelin-receptor-antagonists.
ZA966750B (en) Halogenobenzimidazoles.